Kymera is pioneering a transformative new approach to treating previously untreatable diseases — targeted protein degradation — accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins and advance new treatment options for patients.
| Headquarters | Cambridge, MA |
| Website | kymeratx.com |
| Pipeline | Preclinical |
| @kymeratx | |
| Partners | GSK, Vertex, Sanofi |